About

Andrea Cusack, Chief Executive Officer of Nebu-Flow, brings more than 25 years of pharmaceutical and drug delivery experience spanning GSK, Catalent, West and LEON. Her experience includes scaling small- and medium-size enterprises, securing investment, and developing licensing and strategic partnerships. At Nebu~Flow, Ms Cusack leads commercial strategy, pharmaceutical and investor engagement, ensuring that the company’s technology development remains closely aligned with customer needs and its ambitions for growth and future investment.

Contributions

PULMONARY

INNOVATIVE ACOUSTIC NEBULISER TECHNOLOGY

Andrea Cusack, Elijah Nazarzadeh and John Pritchard share insights into the company’s innovative nebuliser platform, designed to overcome the technical restrictions of current technologies that limit the delivery of advanced medicines to the lungs. They also share an update on the development of new digital features for the Nebu-Flow product range.

More contributions

SUSTAINABILITY

NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

Andrea Cusack discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.